Detalhe da pesquisa
1.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
Can J Psychiatry;
68(1): 5-21, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35975555
2.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
Bipolar Disord;
23(8): 767-788, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34599629
3.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur.
Can J Psychiatry;
66(2): 113-125, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33174760
4.
Sex and Gender Roles in Relation to Mental Health and Allostatic Load.
Psychosom Med;
78(7): 788-804, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27359170
5.
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers.
J Psychoactive Drugs;
: 1-14, 2023 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36921026
6.
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.
J Atten Disord;
27(7): 743-756, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37144295
7.
Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis.
Prog Neuropsychopharmacol Biol Psychiatry;
118: 110575, 2022 08 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35568275
8.
Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.
Brain Sci;
12(8)2022 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36009086
9.
Mindfulness-based cognitive therapy vs. a health enhancement program for the treatment of late-life depression: Study protocol for a multi-site randomized controlled trial.
Front Aging Neurosci;
14: 976636, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36118690
10.
Is the Mood Disorder Questionnaire an appropriate screening tool in detecting bipolar spectrum disorder among substance use populations?
Am J Drug Alcohol Abuse;
37(2): 79-81, 2011 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21142433
11.
[Improved Mental Health Clinical Practice Informed by Digital Phenotyping]. / Le phénotypage digital pour une pratique clinique en santé mentale mieux informée.
Sante Ment Que;
46(1): 135-136, 2021.
Artigo
em Francês
| MEDLINE
| ID: mdl-34597492
12.
Balance Problems, Paralysis, and Angina as Clinical Markers for Severity in Major Depression.
Front Psychiatry;
11: 567394, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33424654
13.
Increased spinal pain sensitization in major depressive disorder: A pilot study.
Psychiatry Res;
246: 756-761, 2016 Dec 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27817904
14.
Allostatic load as a tool for monitoring physiological dysregulations and comorbidities in patients with severe mental illnesses.
Harv Rev Psychiatry;
21(6): 296-313, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24201821
15.
Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis.
Schizophr Res;
151(1-3): 43-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24200418
16.
Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.
Clin Ther;
33(12): 1853-67, 2011 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22133697
17.
Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Clin Ther;
32 Suppl 1: S3-20, 2010.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20152550
18.
Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies.
Prog Neuropsychopharmacol Biol Psychiatry;
34(6): 997-1000, 2010 Aug 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20470848